Vaccine-Induced Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and the Path to Accelerating Development (Determining a Correlate of Protection)

As new public health challenges relating to COVID-19 emerge, such as variant strains, waning vaccine efficacy over time, and decreased vaccine efficacy for special populations (immunocompromised hosts), it is important to determine a correlate of protection (CoP) to allow accurate bridging studies f...

Descripción completa

Detalles Bibliográficos
Autores principales: Sherman, Amy C., Desjardins, Michaël, Baden, Lindsey R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563351/
https://www.ncbi.nlm.nih.gov/pubmed/35153045
http://dx.doi.org/10.1016/j.cll.2021.10.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563351/
https://www.ncbi.nlm.nih.gov/pubmed/35153045
http://dx.doi.org/10.1016/j.cll.2021.10.008

Ejemplares similares